Nanomonitor technology for glycosylation analysis

Gaurav Chatterjee, Manish Bothara, Srivatsa Aithal, Vinay J. Nagraj, Peter Wiktor, Seron Eaton, Shalini Prasad

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Changes in protein glycosylation have great potential as markers for the early diagnosis of cancer and other diseases. The current analytical tools for the analysis of glycan structures need expensive instrumentation, advanced expertise, is time consuming and therefore not practical for routine screening of glycan biomarkers from human samples in a clinical setting. We are developing a novel ultrasensitive diagnostic platform called 'NanoMonitor' to enable rapid label-free glycosylation analysis. The technology is based on electrochemical impedance spectroscopy where capacitance changes are measured at the electrical double layer interface as a result of interaction of two molecules. The NanoMonitor platform consists of a printed circuit board with array of electrodes forming multiple sensor spots. Each sensor spot is overlaid with a nanoporous alumina membrane that forms a high density of nanowells. Lectins, proteins that bind to and recognize specific glycan structures, are conjugated to the surface of nanowells. When specific glycoproteins from a test sample bind to lectins in the nanowells, it produces a perturbation to the electrical double layer at the solid/liquid interface at the base of each nanowell. This perturbation results in a change in the impedance of the double layer which is dominated by the capacitance changes within the electrical double layer. The nanoscale confinement or crowding of biological macromolecules within the nanowells is likely to enhance signals from the interaction of glycoproteins with the lectins leading to a high sensitivity of detection with the NanoMonitor as compared to other electrochemical techniques. Using a panel of lectins, we were able to detect subtle changes in the glycosylation of fetuin protein as well as differentiate glycoproteins from normal versus cancerous cells. Our results indicate that NanoMonitor can be used as a cost-effective miniature electronic biosensor for the detection of glycan biomarkers.

Original languageEnglish (US)
Title of host publicationBiosurfaces and Biointerfaces
Pages21-26
Number of pages6
Volume1236
StatePublished - Dec 1 2010
Event2009 MRS Fall Meeting - Boston, MA, United States
Duration: Nov 30 2009Dec 2 2009

Other

Other2009 MRS Fall Meeting
CountryUnited States
CityBoston, MA
Period11/30/0912/2/09

Fingerprint

Glycosylation
Lectins
Glycoproteins
Polysaccharides
biomarkers
Biomarkers
proteins
Proteins
Capacitance
platforms
capacitance
impedance
Fetuins
perturbation
crowding
Aluminum Oxide
sensors
Sensors
printed circuits
circuit boards

ASJC Scopus subject areas

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering
  • Mechanics of Materials

Cite this

Chatterjee, G., Bothara, M., Aithal, S., Nagraj, V. J., Wiktor, P., Eaton, S., & Prasad, S. (2010). Nanomonitor technology for glycosylation analysis. In Biosurfaces and Biointerfaces (Vol. 1236, pp. 21-26)

Nanomonitor technology for glycosylation analysis. / Chatterjee, Gaurav; Bothara, Manish; Aithal, Srivatsa; Nagraj, Vinay J.; Wiktor, Peter; Eaton, Seron; Prasad, Shalini.

Biosurfaces and Biointerfaces. Vol. 1236 2010. p. 21-26.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Chatterjee, G, Bothara, M, Aithal, S, Nagraj, VJ, Wiktor, P, Eaton, S & Prasad, S 2010, Nanomonitor technology for glycosylation analysis. in Biosurfaces and Biointerfaces. vol. 1236, pp. 21-26, 2009 MRS Fall Meeting, Boston, MA, United States, 11/30/09.
Chatterjee G, Bothara M, Aithal S, Nagraj VJ, Wiktor P, Eaton S et al. Nanomonitor technology for glycosylation analysis. In Biosurfaces and Biointerfaces. Vol. 1236. 2010. p. 21-26
Chatterjee, Gaurav ; Bothara, Manish ; Aithal, Srivatsa ; Nagraj, Vinay J. ; Wiktor, Peter ; Eaton, Seron ; Prasad, Shalini. / Nanomonitor technology for glycosylation analysis. Biosurfaces and Biointerfaces. Vol. 1236 2010. pp. 21-26
@inproceedings{f0cfa6eb0aae458a8997daeb7eafe985,
title = "Nanomonitor technology for glycosylation analysis",
abstract = "Changes in protein glycosylation have great potential as markers for the early diagnosis of cancer and other diseases. The current analytical tools for the analysis of glycan structures need expensive instrumentation, advanced expertise, is time consuming and therefore not practical for routine screening of glycan biomarkers from human samples in a clinical setting. We are developing a novel ultrasensitive diagnostic platform called 'NanoMonitor' to enable rapid label-free glycosylation analysis. The technology is based on electrochemical impedance spectroscopy where capacitance changes are measured at the electrical double layer interface as a result of interaction of two molecules. The NanoMonitor platform consists of a printed circuit board with array of electrodes forming multiple sensor spots. Each sensor spot is overlaid with a nanoporous alumina membrane that forms a high density of nanowells. Lectins, proteins that bind to and recognize specific glycan structures, are conjugated to the surface of nanowells. When specific glycoproteins from a test sample bind to lectins in the nanowells, it produces a perturbation to the electrical double layer at the solid/liquid interface at the base of each nanowell. This perturbation results in a change in the impedance of the double layer which is dominated by the capacitance changes within the electrical double layer. The nanoscale confinement or crowding of biological macromolecules within the nanowells is likely to enhance signals from the interaction of glycoproteins with the lectins leading to a high sensitivity of detection with the NanoMonitor as compared to other electrochemical techniques. Using a panel of lectins, we were able to detect subtle changes in the glycosylation of fetuin protein as well as differentiate glycoproteins from normal versus cancerous cells. Our results indicate that NanoMonitor can be used as a cost-effective miniature electronic biosensor for the detection of glycan biomarkers.",
author = "Gaurav Chatterjee and Manish Bothara and Srivatsa Aithal and Nagraj, {Vinay J.} and Peter Wiktor and Seron Eaton and Shalini Prasad",
year = "2010",
month = "12",
day = "1",
language = "English (US)",
isbn = "9781617822148",
volume = "1236",
pages = "21--26",
booktitle = "Biosurfaces and Biointerfaces",

}

TY - GEN

T1 - Nanomonitor technology for glycosylation analysis

AU - Chatterjee, Gaurav

AU - Bothara, Manish

AU - Aithal, Srivatsa

AU - Nagraj, Vinay J.

AU - Wiktor, Peter

AU - Eaton, Seron

AU - Prasad, Shalini

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Changes in protein glycosylation have great potential as markers for the early diagnosis of cancer and other diseases. The current analytical tools for the analysis of glycan structures need expensive instrumentation, advanced expertise, is time consuming and therefore not practical for routine screening of glycan biomarkers from human samples in a clinical setting. We are developing a novel ultrasensitive diagnostic platform called 'NanoMonitor' to enable rapid label-free glycosylation analysis. The technology is based on electrochemical impedance spectroscopy where capacitance changes are measured at the electrical double layer interface as a result of interaction of two molecules. The NanoMonitor platform consists of a printed circuit board with array of electrodes forming multiple sensor spots. Each sensor spot is overlaid with a nanoporous alumina membrane that forms a high density of nanowells. Lectins, proteins that bind to and recognize specific glycan structures, are conjugated to the surface of nanowells. When specific glycoproteins from a test sample bind to lectins in the nanowells, it produces a perturbation to the electrical double layer at the solid/liquid interface at the base of each nanowell. This perturbation results in a change in the impedance of the double layer which is dominated by the capacitance changes within the electrical double layer. The nanoscale confinement or crowding of biological macromolecules within the nanowells is likely to enhance signals from the interaction of glycoproteins with the lectins leading to a high sensitivity of detection with the NanoMonitor as compared to other electrochemical techniques. Using a panel of lectins, we were able to detect subtle changes in the glycosylation of fetuin protein as well as differentiate glycoproteins from normal versus cancerous cells. Our results indicate that NanoMonitor can be used as a cost-effective miniature electronic biosensor for the detection of glycan biomarkers.

AB - Changes in protein glycosylation have great potential as markers for the early diagnosis of cancer and other diseases. The current analytical tools for the analysis of glycan structures need expensive instrumentation, advanced expertise, is time consuming and therefore not practical for routine screening of glycan biomarkers from human samples in a clinical setting. We are developing a novel ultrasensitive diagnostic platform called 'NanoMonitor' to enable rapid label-free glycosylation analysis. The technology is based on electrochemical impedance spectroscopy where capacitance changes are measured at the electrical double layer interface as a result of interaction of two molecules. The NanoMonitor platform consists of a printed circuit board with array of electrodes forming multiple sensor spots. Each sensor spot is overlaid with a nanoporous alumina membrane that forms a high density of nanowells. Lectins, proteins that bind to and recognize specific glycan structures, are conjugated to the surface of nanowells. When specific glycoproteins from a test sample bind to lectins in the nanowells, it produces a perturbation to the electrical double layer at the solid/liquid interface at the base of each nanowell. This perturbation results in a change in the impedance of the double layer which is dominated by the capacitance changes within the electrical double layer. The nanoscale confinement or crowding of biological macromolecules within the nanowells is likely to enhance signals from the interaction of glycoproteins with the lectins leading to a high sensitivity of detection with the NanoMonitor as compared to other electrochemical techniques. Using a panel of lectins, we were able to detect subtle changes in the glycosylation of fetuin protein as well as differentiate glycoproteins from normal versus cancerous cells. Our results indicate that NanoMonitor can be used as a cost-effective miniature electronic biosensor for the detection of glycan biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=79951982551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951982551&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:79951982551

SN - 9781617822148

VL - 1236

SP - 21

EP - 26

BT - Biosurfaces and Biointerfaces

ER -